46 related articles for article (PubMed ID: 10388073)
1. Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology.
Strauss LG
Oncologist; 1997; 2(6):381-388. PubMed ID: 10388073
[TBL] [Abstract][Full Text] [Related]
2. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
3. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Bar-Shalom R; Kagna O; Israel O; Guralnik L
Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
[TBL] [Abstract][Full Text] [Related]
6. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
7. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
8. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
9. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
Flamen P; Lerut A; Van Cutsem E; Cambier JP; Maes A; De Wever W; Peeters M; De Leyn P; Van Raemdonck D; Mortelmans L
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1085-92. PubMed ID: 11088030
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET in the clinical management of Hodgkin lymphoma.
Hutchings M; Eigtved AI; Specht L
Crit Rev Oncol Hematol; 2004 Oct; 52(1):19-32. PubMed ID: 15363464
[TBL] [Abstract][Full Text] [Related]
11. Assessing tumor response to therapy.
Weber WA
J Nucl Med; 2009 May; 50 Suppl 1():1S-10S. PubMed ID: 19380403
[TBL] [Abstract][Full Text] [Related]
12. Current molecular imaging positron emitting radiotracers in oncology.
Zhu A; Shim H
Nucl Med Mol Imaging; 2011 Mar; 45(1):1-14. PubMed ID: 24899972
[TBL] [Abstract][Full Text] [Related]
13. State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET.
Carlier T; Bailly C
Front Med (Lausanne); 2015; 2():18. PubMed ID: 26090365
[TBL] [Abstract][Full Text] [Related]
14. The sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolism.
Cox BL; Mackie TR; Eliceiri KW
Am J Nucl Med Mol Imaging; 2015; 5(1):1-13. PubMed ID: 25625022
[TBL] [Abstract][Full Text] [Related]
15. Novel PET Radiotracers for Potential Use in Management of Lymphoma.
Kostakoglu L
PET Clin; 2012 Jan; 7(1):83-117. PubMed ID: 27157021
[TBL] [Abstract][Full Text] [Related]
16. Update on Preoperative Parathyroid Localization in Primary Hyperparathyroidism.
Park HS; Hong N; Jeong JJ; Yun M; Rhee Y
Endocrinol Metab (Seoul); 2022 Oct; 37(5):744-755. PubMed ID: 36327985
[TBL] [Abstract][Full Text] [Related]
17. Amino Acid Transporters on the Guard of Cell Genome and Epigenome.
Kahya U; Köseer AS; Dubrovska A
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401748
[TBL] [Abstract][Full Text] [Related]
18. Designing a New Molecular Probe: The Potential Role for Tilmanocept (Lymphoseek
Adesanya OO; Hutchinson CE
Open Orthop J; 2017; 11():212-224. PubMed ID: 28458734
[TBL] [Abstract][Full Text] [Related]
19. Suture Granuloma With False-Positive Findings on FDG-PET/CT Resected via Laparoscopic Surgery.
Takeshita N; Tohma T; Miyauchi H; Suzuki K; Nishimori T; Ohira G; Narushima K; Imanishi S; Toyozumi T; Matsubara H
Int Surg; 2015 Apr; 100(4):604-7. PubMed ID: 25875540
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma.
Shinohara T; Shiota N; Kume M; Hamada N; Naruse K; Ogushi F
BMC Infect Dis; 2013 Jan; 13():12. PubMed ID: 23317113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
